Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $2.46 Million - $10.8 Million
-901,537 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$11.49 - $22.0 $16.7 Million - $32.1 Million
-1,457,069 Reduced 61.78%
901,537 $10.4 Million
Q3 2021

Nov 12, 2021

SELL
$16.35 - $23.4 $2.27 Million - $3.25 Million
-139,055 Reduced 5.57%
2,358,606 $43.9 Million
Q3 2020

Nov 06, 2020

BUY
$17.5 - $30.23 $43.7 Million - $75.5 Million
2,497,661 New
2,497,661 $75.5 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.